Fig. 12From: Predicted antiviral drugs Darunavir, Amprenavir, Rimantadine and Saquinavir can potentially bind to neutralize SARS-CoV-2 conserved proteinsActive site residues & drug binding motifs of NSP3. a, b Two different surfaces showing drug binding motifs in close association with active site residues of the enzyme. Here Anprenavir, Darunavir and Saquinavir targeted active site residue VAL253 in a pocket. 478-Amprenavir; 017-Darunavir; RIM Rimantadine, ROC SaquinavirBack to article page